Shimaa Abdelalim Essa, Ahmed Elokda, Dalia Mosaad, Wael Shendy, Maged Abdel-Nasser, Asmaa Mohamed Ebraheim, Hadeel Mohammad, Alaa Elmazny & Eman Magdy. (2023) Efficacy of ultraviolet B radiation versus vitamin D3 on postural control and cognitive functions in relapsing-remitting multiple sclerosis: A randomized controlled study. Journal of Bodywork and Movement Therapies 35, pages 49-56.
Crossref
Joost Smolders, Øivind Torkildsen, William Camu & Trygve Holmøy. (2019) An Update on Vitamin D and Disease Activity in Multiple Sclerosis. CNS Drugs 33:12, pages 1187-1199.
Crossref
Mariska C Vlot, Laura Boekel, Jolijn Kragt, Joep Killestein, Barbara M. van Amerongen, Robert de Jonge, Martin den Heijer & Annemieke C. Heijboer. (2019) Multiple Sclerosis Patients Show Lower Bioavailable 25(OH)D and 1,25(OH)2D, but No Difference in Ratio of 25(OH)D/24,25(OH)2D and FGF23 Concentrations. Nutrients 11:11, pages 2774.
Crossref
Darius Häusler & Martin S. Weber. (2019) Vitamin D Supplementation in Central Nervous System Demyelinating Disease—Enough Is Enough. International Journal of Molecular Sciences 20:1, pages 218.
Crossref
Gilles Defer, Marc Debouverie, I. Bardou, M. Benamar, R. Bernard-Valnet, P. Branger, D. Brassat, N. Benallègue, F. Calocer, V. Damotte, O. Dejardin, A. Dejean, N. Derache, F. Docagne, C. Donzé, A.-L. Dubessy, B. Fontaine, G. Fournié, A. Fromont, A. Garcia, P. Hautecœur, L. Lanotte, D. Laplaud, B. Le Mauff, H. Lebas, E. Leray, G. Mathey, D. Merkler, L. Michel, M. Michieletto, J. Morille, B. Nicol, C. Pierrot-Deseilligny, S. Pittion-Vouyovitch, I. Rebeix, A. Saoudi, D. Seilhean, B. Stankoff, O. Toutirais, D. Vivien & S. Vukusic. 2019. La Sclérose en Plaques - Historique, épidémiologie et Pathogénie. La Sclérose en Plaques - Historique, épidémiologie et Pathogénie
31
105
.
Sunil J. Wimalawansa. (2018) Non-musculoskeletal benefits of vitamin D. The Journal of Steroid Biochemistry and Molecular Biology 175, pages 60-81.
Crossref
Charles Pierrot-Deseilligny & Jean-Claude Souberbielle. (2017) Vitamin D and multiple sclerosis: An update. Multiple Sclerosis and Related Disorders 14, pages 35-45.
Crossref
T Berge, I S Leikfoss, I S Brorson, S D Bos, C M Page, M W Gustavsen, A Bjølgerud, T Holmøy, E G Celius, J Damoiseaux, J Smolders, H F Harbo & A Spurkland. (2016) The multiple sclerosis susceptibility genes TAGAP and IL2RA are regulated by vitamin D in CD4+ T cells. Genes & Immunity 17:2, pages 118-127.
Crossref
M.C. Martinez-Altarriba, O. Ramos-Campoy, I.M. Luna-Calcaño & E. Arrieta-Antón. (2015) Revisión de la esclerosis múltiple (1). A propósito de un caso. SEMERGEN - Medicina de Familia 41:5, pages 261-265.
Crossref
Agnes E. Nystad, Stig Wergeland, Lage Aksnes, Kjell-Morten Myhr, Lars Bø & Øivind Torkildsen. (2014)
Effect of high-dose 1.25 dihydroxyvitamin D
3
on remyelination in the cuprizone model
. APMIS 122:12, pages 1178-1186.
Crossref
Fernando ShahijanianGrant P. ParnellFiona C. McKayPrudence N. GattMaryam Shojoei, Kate S. O'ConnorStephen D. SchibeciFabienne Brilot, Christopher LiddleMarcel Batten, Graeme J. StewartDavid R. Booth. (2014) The CYP27B1 variant associated with an increased risk of autoimmune disease is underexpressed in tolerizing dendritic cells. Human Molecular Genetics 23:6, pages 1425-1434.
Crossref
Ifigenia Kostoglou-Athanassiou, Panagiotis Athanassiou, Anastasios Gkountouvas & Philippos Kaldrymides. (2013) Vitamin D and glycemic control in diabetes mellitus type 2. Therapeutic Advances in Endocrinology and Metabolism 4:4, pages 122-128.
Crossref
Charles Pierrot-Deseilligny & Jean-Claude Souberbielle. (2013) Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis. Therapeutic Advances in Neurological Disorders 6:2, pages 81-116.
Crossref